- Home
- KYMR vs SKE Comparison
KYMR vs SKE Comparison
Compare KYMR & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | SKE |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 2.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | SKE |
|---|---|---|
| Price | $89.53 | $24.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $101.43 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 656.1K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,735,000.00 | N/A |
| Revenue This Year | $20.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $8.53 |
| 52 Week High | $103.00 | $26.05 |
Technical Indicators
Market Signals| Indicator | KYMR | SKE |
|---|---|---|
| Relative Strength Index (RSI) | 72.51 | 74.22 |
| Support Level | $86.23 | $20.33 |
| Resistance Level | $93.82 | $21.80 |
| Average True Range (ATR) | 4.66 | 1.14 |
| MACD | 2.34 | 0.45 |
| Stochastic Oscillator | 65.66 | 80.00 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About SKE Skeena Resources Limited
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.